Sichenzia Ross Ference Carmel LLP 代表 AEON Biopharma 进行 2000 万美元的公开发行 By Sichenzia Ross Ference LLP | 6 1 月, 2025 AEON Biopharma, Inc. $20,000,000 Public Offering January 2025 Read More
Sichenzia Ross Ference Carmel LLP 代表 Safe & Green Holdings Corp. 进行 240 万美元的认股权证诱导 By Sichenzia Ross Ference LLP | 7 11 月, 2024 Safe & Green Holdings Corp. $2,400,000 Warrant Inducement November 2024 Read More
Sichenzia Ross Ference Carmel LLP 代表 Qualigen Therapeutics, Inc. 公开发行 347 万美元 By Sichenzia Ross Ference LLP | 6 9 月, 2024 Qualigen Therapeutics, Inc. $3,470,000 Private Placement September 2024 Read More
Sichenzia Ross Ference Carmel LLP 代表 La Rosa Holdings Corp. 进行 500 万美元的 IPO By Sichenzia Ross Ference LLP | 10 10 月, 2023 La Rosa Holdings Corp. $5,000,000 initial Public Offering Common Stock October 2023 Read More
Sichenzia Ross Ference LLP 代表 Murphy Canyon Acquisition Corp. 与 Conduit Pharmaceuticals Limited 进行业务合并 By Sichenzia Ross Ference LLP | 22 9 月, 2023 Murphy Canyon Acquisition Corp. Business Combination September 2023 Read More
西森齐亚·罗斯·费伦斯律师事务所代表Madison Global Partners, LLC进行authID Inc. 820万美元的同时注册直接发行和私募证券交易。 By Sichenzia Ross Ference LLP | 2 6 月, 2023 authID, Inc. $8,200,000 Direct Offering June 2023 Read More